1. MDSC and beyond: a symposium-in-writing on myeloid cells with immunoregulatory activity by members of the Mye-EUNITER network

   • Sven Brandau

   Editorial 18 March 2019 Pages: 531 - 532

2. Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice

   • Elodie Pliquet
   • Claude Ruffie
   • Pierre Langlade-Demoyen

   Original Article 17 January 2019 Pages: 533 - 544

   

3. Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma

   • Vaianu Leroy
   • Emilie Gerard
   • Anne Pham-Ledard

   Original Article 19 January 2019 Pages: 545 - 551

   

4. Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma

   • Hamzah Abu-Sbeih
   • Faisal S. Ali
   • Yinghong Wang

   Original Article 21 January 2019 Pages: 553 - 561

   

5. Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe?

   • Julia Schollbach
   • Stefan Kircher
   • Stefan Löb

   Original Article 22 January 2019 Pages: 563 - 575

   

6. A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients

   • Ryungsa Kim
   • Ami Kawai
   • Koji Arihiro

   Original Article 23 January 2019 Pages: 577 - 585

   

7. Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics

   • Anna Felberg
   • Aleksandra Urban
   • Marcin Okrój

   Original Article Open access 06 February 2019 Pages: 587 - 598

   

8. The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma

   • David Agdashian
   • Mei ElGindi
   • Firouzeh Korangy

   Clinical Trial Report 28 January 2019 Pages: 599 - 608

   

9. Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

   • Sandra P. D’Angelo
   • Matthias Hunger
   • Murtuza Bharmal

   Clinical Trial Report Open access 05 February 2019 Pages: 609 - 618

   

10. A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma

    • Lorena P. Suarez-Kelly
    • Kala M. Levine
    • William E. Carson

    Clinical Trial Report Open access 06 February 2019 Pages: 619 - 629

    

11. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions

    • Annika M. Bruger
    • Anca Dorhoi
    • Sven Brandau

    Symposium-in-Writing Paper 21 May 2018 Pages: 631 - 644

12. Interactions among myeloid regulatory cells in cancer

    • Viktor Umansky
    • Gosse J. Adema
    • Zvi G. Fridlender

    Symposium-in-Writing Paper 12 July 2018 Pages: 645 - 660

    

13. Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation

    • Giada Amodio
    • Joanna Cichy
    • Silvia Gregori

    Symposium-in-Writing Paper Open access 24 October 2018 Pages: 661 - 672

    

14. MDSCs in infectious diseases: regulation, roles, and readjustment

    • Anca Dorhoi
    • Estibaliz Glaría
    • Annabel F. Valledor

    Symposium-in-Writing Paper 19 December 2018 Pages: 673 - 685

    

15. Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates

    • Luca Cassetta
    • Espen S. Baekkevold
    • Gosse J. Adema

    Symposium-in-Writing Paper Open access 25 January 2019 Pages: 687 - 697

    

16. Acknowledgements

    ACKNOWLEDGEMENT TO REVIEWERS 15 March 2019 Pages: 699 - 703